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Abstract
This Doctor of Nursing Practice project will inform the audience of stroke awareness as it
pertains to oral contraceptives. The study’s focus was to enhance the knowledge of African
American women ages 20–40 that have used or are currently using an oral contraceptive. It has
been identified that this patient population lacked the knowledge regarding stroke and oral
contraceptives, and African American women continue to have the highest incidence of stroke.
African American women also make up more than half of the consumers utilizing oral
contraceptives. An oral contraceptive knowledge questionnaire was utilized from previous
research to determine if any differences exist. A 16-question pre- and posttest was administered
to participants and a brief Zoom educational session regarding oral contraceptive use, benefits,
risks, and stroke risk factors and symptoms. There was a quantitative study used to ascertain
participants’ understanding of oral contraceptives and the effects of stroke. A Fisher’s exact test
was used to determine a real difference between the pre- and posttest scores. Despite most
participants holding graduate degrees, the findings revealed a knowledge gap existed prior to
holding the educational session. Overall, there was a positive effect noted because of the
utilization of oral contractive and stroke education sessions. The most significant finding was an
awareness of the risk of acquiring blood clots or stroke with oral contraceptive use.
Keywords: oral contraceptive, contraceptive knowledge, stroke, stroke prevention,
African American women
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Chapter 1: Introduction
This Doctor of Nursing Practice (DNP) project examined ways to increase patients’
knowledge of oral contraceptive and stroke prevention in African American women ages 20–40.
Stroke is the fifth leading cause of death in the United States, affecting more African American
women than men (Centers for Disease Control and Prevention [CDC], 2020). The use of oral
contraceptives with combination hormone therapy poses the highest risk for a vascular incident
(Schuiling & Likis, 2013). The use of oral contraceptives is not typically viewed as a risk factor;
however, birth control pills increase women’s risk from 1.9 times to 8.5 times for stroke (Loyola
University Health System, 2018). This increase, along with other risk factors, can significantly
impact the health of women. The use of oral contraceptives is a modifiable risk factor of which
many women are unaware.
Problem Statement
Many women use oral contraceptives for family planning and medical purposes, such as
acne and menstrual cycle regulation. Regardless of the reasoning, many women are still unaware
of the risks associated with the use of oral estrogen contraceptives. This quality improvement
project implemented an intervention program to educate about the risk factors and provide
awareness to potentially reduce stroke incidence related to oral estrogen contraceptives.
Background
This section will discuss the issue of cardiovascular diseases. This has been at the
forefront of healthcare for quite some time, and more specifically, cardiovascular disease topics
of risks, rates, and prevention as it pertains to African American women. According to the CDC
(2020), African American women in the United States have twice as many stroke incidences than
their Caucasian counterparts. Research has also noted African American women have strokes at
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younger ages and increased severity than other ethnicities (CDC, 2020). Many risk factors are
contributing to these higher incidences. The first risk factor is high blood pressure (i.e.,
hypertension). African American women tend to acquire hypertension at younger ages and are at
double the rate of Caucasian women. Sensitivity to the effects of salt and sodium intake may be
the rationale behind the disparities in hypertension rates (CDC, 2020). Genetic blood disorders
such as Sickle cell anemia may also alter blood cells, causing blockage and stroke. Obesity and
diabetes are also higher in African American women, resulting in an increased risk of stroke
(CDC, 2020). Other risk factors include the use of combination hormonal therapy, oral
contraceptives, and pregnancy (CDC, 2020).
In 2015–2017, 72.2 million women ages 15–49 in the United States used contraceptives
(Daniels & Abma, 2018). African American women represent 59.9% of the population using
contraceptives (Daniels & Abma, 2018). Family planning is an essential part of women’s lives.
Women knowing the risks are key to prevention. Although the primary goal for most
contraceptive use is family planning, the use of contraceptives comes with risks and side effects,
and some may be debilitating or life-threatening. One common side effect is developing blood
clots, which could lead to stroke (Schuiling & Likis, 2013). A blood clot can occur because of
pregnancy, oral contraceptives, hypertension, or high cholesterol (Mayo Clinic, 2020) factors,
causing it to obstruct or burst and preventing adequate oxygen blood flow to the brain (American
Stroke Association [ASA], 2020). The effects of inadequate oxygenation in the brain causes
what is known as a stroke. This lack of oxygen to the brain affects not only the brain but also
ultimately affects other functions of the body, such as speech, vision, and body movement (ASA,
2020). The current recommendations for prescribing oral contraceptives advises against doing so
in women with blood pressure readings >160/100, vascular disease, complicated diabetes, and
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women older than 35, and those who smoke more than 15 cigarettes per day (CDC, 2013).
Stroke is a debilitating disease and causes not only mental and physical burdens but also
financial burdens on patients and families. Incidents of stroke have been noted in younger
women aged 35–64 (Tong et al., 2019).
Purpose of the Study
This study aimed to understand women’s knowledge gap with oral contraceptive use and
stroke. On average, 90% of women have at least one risk factor for heart disease or stroke, and
African American women explicitly have the highest stroke rate (American Stroke Association
[ASA], 2020). This project aimed to provide education and awareness of stroke-related risks
associated with oral contraceptive use in African American women ages 20–40.
Although the research efforts are minimal regarding stroke and oral contraceptive use,
this research’s primary focus was preventative based. Obtaining knowledge of patients’
understanding of risks regarding oral contraceptive use was done through questionnaires. This
tool was used to determine any knowledge gaps regarding oral contraceptive use and stroke. This
quality improvement project focused on bringing awareness about risk factors associated with
oral contraceptive use and stroke. The initiation of educating as an intervention was necessary to
prevent the subsequent incidence effects of stroke from oral contraceptive use.
Significance
This topic selection was based on the limited research on stroke and oral contraceptive
use. Despite the limited research, stroke is a debilitating and, in some cases, a deadly disease. On
average, stroke affects one in four people nationwide (ASA, 2020). More specifically, strokes
affect more women than men; one in five to be exact (ASA, 2020). With more women affected
by this disease, it is cause for increased awareness and interventions. Educating patients on their
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risks is key to understanding and decreasing stroke while using oral contraceptives. According to
the American Stroke Association (2020), about 80% of clot-related strokes are preventable. The
high prevention rate creates a clinical need to mitigate future incidence.
Nature of the Project
The goal of this DNP project was to educate and create awareness for providers and
patients concerning risk factors. A collaborative effort involving the patient and provider is key
to decreasing incidences of strokes. In doing so, creating measures to ensure the patients can
effectively and safely practice family planning or use of contraceptives is vital.
Question Guiding the Inquiry
Q1. Will an evidence-based educational session assist with increasing awareness of
stroke with oral contraceptive use in African American women ages 20–40?
P (patient population): African American women ages 20–40 using or who have used oral
estrogen contraceptives.
I (intervention): Stroke prevention information, including risk factors, signs, and
symptoms. Educate patients with a stroke prevention course.
C (comparison): Pre- and posttest questionnaires to determine the knowledge base of the
participants.
O (outcomes): Bridge the knowledge gap regarding oral contraceptive use and stroke.
Long-term goals are to decrease oral estrogen contraceptive-related stroke incidence in African
American women ages 20–40.
T (time): The time frame scheduled to complete this project was three months. This time
allotment included recruitment and a one-day, two-hour session that included questionnaires and
data analysis.
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The research hypothesis was that educating African American women ages 20–40 on oral
contraceptives using an evidence-based tool displayed a difference in their knowledge of oral
contraceptives and stroke risk factors and clinical manifestation.
Theoretical Framework
Dr. Martha Rogers created the science of unitary human being theoretical framework.
Rogers was a doctoral degree nurse who also taught in academia. It was her belief system that
nursing required a collaborative effort of science and art (Nursing Theory, 2016). The science of
nursing is knowledge- and research-based. The art of nursing consists of interventions and
outcomes. A holistic view of nursing and caring for patients encompasses Rogers’ theory. This
multifaceted theory aligns with mitigating the clinical inquiry problem of interest (POI)
prevention of stroke in women using oral contraception.
Martha Rogers’ science of unitary human being nursing theory was selected based on the
holistic view (Nursing Theory, 2016). Holistically caring for patients is imperative to educate
and empower effectively. Providing women with proper education of birth control options
should not be biased but evidence-based (Schuiling & Likis, 2013). Health promotion, serving
the patient, and providing safe practice based on the clinician’s expertise and skills are vital
components of Rogers’ theory (Nursing Theory, 2016). A collective inclusion of sharing
knowledge, offering choices, empowering the patient, evaluating, and self-awareness of both the
human and environmental fields will aid in addressing this POI (Nursing Theory, 2016; see
Figure 1, which I created).
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Figure 1
Unitary Theoretical Framework

Operational Definitions
Standard vital terms were used during the research of this topic. However, some of these
key terms are not commonly used and require clarification. Throughout this paper, these key
terms will be utilized. These definitions are set in place to provide clarity to understand the topic
of oral contraceptives and stroke.
Blood clots. Blood clots are clumps of hardened blood in the arteries or veins (Mayo
Clinic, 2020).
D-dimer. Blood sample test used to determine how blood is clotting (Raffield et al.,
2017).
Ischemic stroke. A type of stroke where there is an obstruction of oxygenated blood to
the brain (ASA, 2020).
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Oral contraceptive. Oral contraceptives are medications taken daily containing two
types of hormones (estrogen and progesterone; Schuiling & Likis, 2013).
Scope and Limitations
This study focused on the effects of a knowledge deficit about stroke risk factors in
African American women ages 20–40 taking oral contraceptives. A knowledge-based
questionnaire of the mechanism of action, use, risk, and side effects was given to patients from
May–July 2020. Limitations arose during the research outside of my control, such as the loss of
participants. Another limitation was the time frame in which the patients received the educational
session and the posttest questionnaire. It could not be verified that the information was retained
or if it was from short-term memory. While I cannot control the participant’s involvement or
retention of the information, I was mindful of these limitations. These obstacles do affect the
results of the research. Hence, it is also possible that future researchers may doubt the conclusion
of this study and its results.
Chapter Summary
This research aimed to improve the knowledge of African American women ages 20–40
in understanding the side effects of oral contraceptives and stroke symptoms when using or
previously having used oral contraceptives. The study did enhance patients’ knowledge to make
the safest oral contraceptive choice while considering the risk factors. It also gave providers
insight as to where the knowledge gaps are being missed.
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Chapter 2: Literature Review
Stroke has become a more prominent topic since the recent deaths of famous actors.
Research has found a correlation between estrogen-based oral contraceptives and blood clots
(Camara et al., 2017). Despite these research efforts, there is still limited literature on strokerelated oral contraceptive use. Implementing Rogers’ unitary theory with the POI provided a
more effective means of ensuring the patient is being addressed. Rogers’ unitary theory
addresses the first component of this quality improvement project by empowering the patient
through education. Providers do so by ensuring patients are aware of their risks, benefits, and
options regarding oral contraceptives and stroke. Promoting health and wellness through an
educational course will provide empowerment for these women to make informed health
decisions. The next component is utilizing the knowledge from evidence-based research that
displays competence from compassionate caregivers while providing patient-centered care. The
collaborative effort of evidence-based research and nursing art can guide the process of health
promotion. The evidence-based research used an innovative approach to incorporating
technology to educate patients. As a result, slight improvements were seen in patient knowledge
of oral contraception. It was vital to address risks and side effects as well as the mechanism of
action and effectiveness. A comprehensive approach to care can enhance patient education and
health (Hall et al., 2013).
The Abilene Christian University (ACU) library provides a variety of options when
searching for research literature. Research guides offer diverse categories in areas such as
theology, business, psychology, nursing, education, and management. I selected the DNP link,
then the CINAHL link, which took me to EBSCOhost. According to information on the Georgia
State University Library (2018) site, it was very imperative to start with the most recent research
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and progress to the oldest. Research for this topic was done based on literature over the last six
years to provide the most accurate data (Georgia State University Library, 2018).
After completing the search, a full-text article box was selected. Including keywords and
terms narrowed the search further. The first selected word was stroke followed by optional
secondary words such as African American women. With these options, a total of 2,769 research
articles were obtained. Narrowing the search for specifics was another option in using keywords
such as blood clots and contraceptives, which provided additional research articles. Next, I
determined the level of evidence-based articles from the American Association of Critical Care
Nurses strength level of proof. Once this was completed, the search was narrowed by attempting
to select level 1 evidence-based articles that contained systematic reviews and meta-analysis and
then randomized controlled trials and cohort studies. The next level of evidence was case-control
studies, and this was done by using the level of evidence pyramid (Peterson et al., 2014).
Influence of Hormonal Contraceptives and the Occurrence of Stroke
The first research study utilized the critical care nurses rating scale. The research article
consists of qualitative studies, descriptions, correlations, and is an integrative review (Peterson et
al., 2014). This selected article discussed the influence of contraceptives and the occurrence of
stroke. The hypothesis determined if estrogen-based hormones increased clotting factors that
caused a clot, leading to stroke. Variables included the duration of use, risk factors, combined
contraceptives, and the type of stroke. The study design was performed using an integrative
review, which reviewed a variety of case-control studies from various databases such as
CINAHL, Medline, PubMed, and Cochrane. There was a mixture of case-control and a cohort
study with 323 to 98,790 women participants ranging in ages from 15 to 49. Surveys were
completed in the United States, China, the United Kingdom, Africa, Asia, Europe, Australia,
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Latin America, Denmark, and Sweden. Studies were published from 1986–2014. References
cited in this integrative review were dated from 2011–2014. Because the data were from a
Brazilian journal, biases from the results could be attributed to that factor.
Similarities were seen in studies of women who used the third-generation or low dose
combination of estrogen and progesterone contraception that increased coagulation factors with
the possibility of triggering a stroke (Camara et al., 2017). Differences found were the location of
studies, participants used, types of birth control, and types of stroke. Limitations found in this
study were it being integrative as opposed to a literature review. Specific databases were used,
which may have limited results available (Camara et al., 2017). Strengths of this study were the
diverse methodology of studies and locations to obtain data and complete the research. The
weakness was that an integrative review generally does not use a rigorous method. As a result,
the author’s conclusions and recommendations may be deemed as biased (Melnyk & FineoutOverholt, 2015). A limitation of this study was the exclusion of literature review studies (Camara
et al., 2017). This study’s findings advise that ethinyl estradiol in the combined oral
contraceptive leads to the risk of stroke with no increases from the user of progesterone-only
hormone therapy (Camara et al., 2017).
The integrative study provided data regarding differences in estrogen and progesteronebased hormones. The study utilized various categories based on hormones and the risk of stroke,
dosage, duration of use, and risk associated with stroke (Camara et al., 2017). Some barriers for
this study were the time frame in which the reviews were completed and the need to obtain more
recent data. For example, no current information addressing stroke and the vaginal ring was
incorporated (Camara et al., 2017). To achieve the most accurate data for adverse effects of
contraceptive, inclusion of all types would need to be done.
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Impact of an Educational Text Message Intervention on Young Urban Women’s
Knowledge of Oral Contraception
The institutional review board of Columbia University approved the second evidencebased research study of an educational text message questionnaire for young adult women (Hall
et al., 2013). There was a total of 659 women ages 13–25 in the study (Hall et al., 2013). Of the
659 participants, 84% were African American, 41% Caucasian, 25% Hispanic, and 5% Asian
and other, who were currently sexually active and living in the inner city (Hall et al., 2013). On
average, educational attainment was a sophomore level in college (Hall et al., 2013). Initially, a
baseline survey was given, followed by daily informative texts for six months. In the end, a
comprehensive 41-item questionnaire was administered. There was a combination of telephone
interviewing and text message questions. Question content included risks and benefits,
effectiveness, mechanism of action, and side effects (Hall et al., 2013). Most research focused on
improving knowledge of side effects. The goal of this research was to fill the knowledge gap of
efficacy, benefits, and understanding how birth control works (Hall et al., 2013). According to
Hall et al.’s (2013) research results, most improvement was shown in the knowledge of oral
contraception, including mechanism of action, benefits, and effectiveness. One strength of this
study is it is peer-reviewed research that uses the gold standard of random controlled trial
methodology (Keele, 2011).
This research’s level of evidence is based on the AACN’s leveling system that utilizes
expert opinions from obstetrics and epidemiology articles from multiple case reports (Peterson et
al., 2014). Strengths of this study included the method of RCT and the use of descriptive
statistics, bivariate, and analysis of variance (ANOVA) to compare scores. These tools assisted
in determining the reliability and validity of the study (Keele, 2011). The weakness found in the
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survey was the inability to see if patients were accurately answering questions on their own or
doing a Google search for information. Findings in this study displayed the most improvement in
knowledge regarding the mechanism of action and effectiveness (Hall et al., 2013). This study
provided interventions for educating young women on an oral contraceptive. The study also
implemented an innovative means of providing health education to the youth. Incorporation of
technology is a great tool to assess and evaluate the effectiveness of knowledge of oral
contraceptive use. Despite this study providing more implementation for my PICOT, there were
limitations in the reliability and validity of this study (Hall et al., 2013).
Women and Stroke Knowledge
The third research article discussed women and their knowledge of stroke based on age,
race, location, or marital status. A stroke recognition questionnaire (SRQ) of 40 stroke symptoms
and factors was given. The sample size of the study consisted of 97 middle-aged women in the
Southeast region. This research also gathered opinions from experts in nursing and psychology,
and its hypothesis was about a woman’s knowledge of stroke and if any influential factors
existed. Two strengths were found in the study. The first was using a conceptual framework of
the common-sense model (CSM). This framework enabled my interruption of participants’
actions regarding their thoughts of illness (Ennen & Beamon, 2012). The study design was a
descriptive quantitative nonexperimental design and received approval from the institutional
review board. Because multiple factors existed, the study also used ANOVA testing (Ennen &
Beamon, 2012). In addition, a content validity index (CVI) was implemented to determine
reliability (Ennen & Beamon, 2012). The second strength was the credibility of the research
performed as it utilized evidence-based information and used peer reviews.
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The weakness of the study included the fact the questions were yes or no, in which the
participant has a 50/50 chance of answering correctly. Findings included no significant
differences in recognition of stroke by residence location (i.e., rural or urban). Participants with
income less than $22,200 a year had difficulty identifying coordination as a symptom (Ennen &
Beamon, 2012). There was no significance in stroke risk factors by residence (Ennen & Beamon,
2012). A Tukey’s post hoc test revealed that African American women had significantly lower
scores for risk factors than any other race (Ennen & Beamon, 2012). Limitations of this study
included participants guessing on the questions. The small sample size also consisted of
primarily educated Caucasian women. As a result, this would not have given researchers the
most appropriate data to include regarding consumers knowledge of health. Another limitation
was the participants being in a weight loss program. These participants may have been more
knowledgeable regarding the signs and symptoms of a stroke (Ennen & Beamon, 2012).
Therefore, these limitations would create the question as to the adequacy of the research and
results received from this study. The third research study also provided clinicians with a
background on the knowledge of women and health. The difference in this focus was on stroke
knowledge with influential factors present. As women carry the highest prevalence of stroke,
understanding the rationale behind the disparity is vital before interventions can be implemented.
As clinicians, we must first obtain the necessary data, like the items found in this research, to
move forward. The difference in this study was the age of the participants and the inclusion of all
ethnicities.
Assessment of Vascular Disease Prevention Practices in Urban Women
The fourth research study focused on assessing preventative measures for cardiovascular
disease and whether it is acceptable in women over 40 years old. This cross-sectional study was
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completed using data obtained from the patients’ charts. The sample size was 1,815 women ages
40 and older in five metropolitan primary care offices (Chaturvedi et al., 2016). Data included
patient’s risk factors such as diabetes, hypertension, and hyperlipidemia. Patients with a history
of heart disease (e.g., stroke and atrial fibrillation) were also included in the study. Those
receiving treatment for the above risk factors, either as primary or secondary, were vital
components to this three-month study. The goal of this study was to determine if preventative
measures of CVD were enough for women aged 40 or older. Chi-square tests were used to
categorize variables and findings, including comparisons among ethnicities (Chaturvedi et al.,
2016). Results of the study stated a higher body mass index for urban patients, as well as higher
risk factors for heart disease and stroke than suburban women (Chaturvedi et al., 2016). There
were gaps in preventative efforts of cardiovascular disease in young women (Chaturvedi et al.,
2016). Also, the use of statin drugs increased with a diabetes diagnosis (Chaturvedi et al., 2016).
The study was limited in many ways, including the lack of incorporation of all cardiovascular
risk factors. It was also biased in it only included participants from private practices associated
with medical schools (Chaturvedi et al., 2016). Another limitation was determining adherence to
primary and secondary pharmacological therapy. It is recommended that the implementation of
cardiovascular risk screening be performed, specifically with young women using the
Framingham risk score in the electronic medical record (Chaturvedi et al., 2016).
Risk Factors for Thrombosis in an African Population
Another research article focused on the risk factor of clots (i.e., thrombosis) in
individuals of African descent. Genetics often play a role in many disease processes. This
research is centered on risk factors and clinical manifestations of venous thromboembolism
(VTE) and pulmonary embolism (PE; Fall et al., 2014). Research has found more incidences of
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VTEs in northern regions such as Europe versus the Mediterranean (Fall et al., 2014). Although
findings were able to narrow down prevalence, etiology is unknown. The study used a crosssectional case-control study with 150 cases and 200 controls. The sample age ranged from 17 to
78, with an average age of 42. Patients for the dependent variable were recruited from hospitals
in Dakar, Senegal, with suspected DVT, or PE, and those with a history of DVT (Fall et al.,
2014). The independent variable patient population was recruited from “healthy blood donors
with no history of thrombosis” (Fall et al., 2014, p. 2). The remaining control group included
patients over 65, receiving testing preoperatively. The sampling of participants’ blood was
analyzed for cell count, blood type, hematologic disorders, and antibodies.
One strength of this study was the length of time obtaining data over three years for
consistency with results. Another advantage was the use of statistical analyses measuring risk
factors with logistic regression (Fall et al., 2014). A confidence interval of 95% proved in favor
of the findings. A significant outcome of the study was the association of anti-phospholipid
(APL) antibodies and DVT. Patients had four times more occurrence risk of DVT with a
presentation of APL antibodies (Fall et al., 2014). Another finding was a decrease in protein S,
an anti-clotting factor, which increases the risk of clots 15 times more than others (Fall et al.,
2014). Females also displayed a higher risk of acquiring clots and were mostly related to
obstetrics and birth control.
Burden of Cerebrovascular Disease in the United States
Cerebrovascular disease (CVA) is defined as anything that affects the veins or arteries
leading to the brain such as stroke, carotid, vertebral, intracranial stenosis, aneurysms, and
vascular malformations (American Association of Neurological Surgeons [AANS], 2020).
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According to the AANS (2020), CVA is known as the most common life-threatening event with
ischemic stroke contributing to 10% of strokes worldwide.
Stroke affects millions and is the leading cause of long-term disability in the United
States (AANS, 2020). The burden of disease has many effects, ranging from physical, mental,
and financial burdens. This study focused on the burden of CVA in adults 35 years and older.
The study aimed to provide the most recent estimated cost of both fatal and nonfatal CVA events
in the United States based on age, sex, and location from 2006–2014. Although there have been
noted decreases in mortality rates in the United States since the 1900s, stroke continues to remain
the fourth leading cause of death for women and fifth leading cause of death for men (Tong et
al., 2019). The research identified 795,000 new or reoccurring cases per year. On average, 25%
of stroke survivors have reoccurrence in the first five years (AANS, 2020). This study utilized
data from the nationwide emergency department sample (NEDS) to examine visits of
hospitalized adults 35 years and older. According to Tong et al. (2019), an estimated annual
directed medical cost for a stroke is $17.9 million from 2012 to 2013. Additionally, an increase
in mortality among younger adults ages 35–64 was also noted. One point three million CVA
events were simultaneously noted, along with other chronic diseases (Tong et al., 2019). This
rate increased by 36% among young adults, ages 35–64, from 2006–2014 (Tong et al., 2019).
Research has also identified the southern region as having the highest CVA events (Tong et al.,
2019).
The strength of this study was the use of a NEDS and obtaining national estimates in the
United States (Tong et al., 2019). Another strength was the inclusion of both fatal and nonfatal
CVA events. Limitations of this study included the inability to capture patients in outpatient
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settings and repeat emergency room visits. It also excluded transient ischemic attacks (i.e., TIA),
also known as a mini-stroke (Tong et al., 2019).
Chapter Summary
Research has found that estrogen-containing contraceptives do increase clotting factors
and the possibility of stroke. However, additional research is required to determine impairments
women suffer from a stroke because of estrogen-based contraceptive use (Camara et al., 2017).
Implementing six months of educational interventions via the use of technology such as text
messaging to the youth is innovative and much needed. However, there was still a participant
knowledge deficit in uneducated, unemployed minority women. Also, there was an overall
disparity in the knowledge of side effects from contraceptive use. This was a significant
intervention, but it did not address the concern of risks or side effects, nor did it incorporate the
age group of women this quality outcome project intended to capture.
Research studies gave insight into how women understood signs and symptoms of a
stroke. Studies also provided factors that may influence women’s knowledge or lack of
knowledge on the topic of stroke. Although my focus was on women ages 20–40, one study did
provide insight into what type of study design could be used to obtain the data. It is understood
women of all ages are being affected by stroke, and interventions are very much needed;
however, more research is necessary to ensure a decrease is seen in incidence across the
spectrum. It has been challenging to locate analysis solely performed on stroke because of
contraceptives. One drawback may be the lack of reporting the incidence. This drawback may be
a fault on the consumers as some may not be aware of the steps to take to report adverse effects
from medications accurately. The primary goal is to provide educational intervention. Once
effective education of adverse side effects, signs, and symptoms of a stroke are achieved,
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progression can be made. The next step for clinicians would be to ensure proper follow-up is
being completed.
The burden of stroke affects patients and families in many ways. The burden has become
more prevalent among the younger population. To mitigate this burden in public health overall,
the aim should be at the prevention level. Providing health and wellness strategies to educate the
public will be vital in mitigating incidences in the younger population. Promoting awareness of
risk factors and aiding in improving lifestyle and behavior changes are some strategies that may
aid in addressing the burden of stroke among the younger population (Tong et al., 2019).
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Chapter 3: Methodology
This project focused on determining a patient’s knowledge base of acquiring blood clots
while using oral contraceptives resulting in a stroke. Current evidence advises protocol for
prescribing oral contraceptives that are based on medical history. Obtaining blood pressure, body
mass index (BMI), and baseline weight are necessary before prescribing oral contraceptives
(CDC, 2020). Evidence-based research has found that women with elevated uncontrolled blood
pressure reading (systolic >160 and diastolic >99) should avoid the use of oral contraceptives.
Additionally, women who have a history of breast cancer, vascular or heart disease, migraine
headaches with aura, certain liver diseases, and are older than 35 who smoke more than 15
cigarettes a day are advised against using oral contraceptives (CDC, 2020). There are no current
recommendations for testing clotting factors before prescribing. This study aimed to provide
education and awareness on risk factors to patients while limiting the impact of stroke-related
symptoms to oral contraceptive use.
Project Design
I was responsible for all project activities, including consent forms, a demographic form,
an educational session, and pre- and postquestionnaires. Those women meeting inclusion were
the target population. Participants were given full disclosure of the study’s aim and methods
before receiving and signing consent. Participants were also allowed to withdraw consent and
participation in the study at any time without penalty. The demographic form consisted of age,
education, oral contraceptive type and length of time of use, the reasoning for taking an oral
contraceptive, and smoking and stroke history. The educational session was based on the
question of content and evidence-based literature using Zoom video conferencing with a question
and answer period at the end of the session.
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Instruments and Measurement Tools
A knowledge-based questionnaire created in 2012 by Dr. Kelli Hall, Dr. Carolyn
Westhoff, and Dr. Paula Castano was selected for use in this research. The oral contraceptive
knowledge questionnaire primarily focused on the content of use, risk benefits, and side effects.
Written permission was requested to use the knowledge-based questionnaire to avoid plagiarism.
Permission was granted in writing via email from Dr. Hall (see Appendix A). The oral
contraceptive knowledge questionnaire was used to evaluate randomly selected participants’
knowledge before and after receiving educational information.
This innovative tool was the most effective in determining patients’ understanding of oral
contraceptive use and stroke risks. This oral contraceptive knowledge questionnaire was used in
two other studies in 2010 and 2013, which used the pre- and postquestionnaire to determine the
participants’ baseline knowledge of oral contraceptives compared to their knowledge
posteducational counseling. According to Hall et al. (2013), oral contraceptive knowledge was
low among young women. Lower scores were significant in younger, less educated minority
women. The study also stated the need for more interventions to improve knowledge of
contraceptive use and side effects. This tool is key to determining if a knowledge deficit exists
with women using an oral contraceptive. I used a five-point Likert scale as the measurement,
including true or false responses, multiple-choice, alternative, and open-ended responses.
Question content consisted of a mechanism of actions, benefits, side effects, risks, and use of
oral contraceptives. The assessment tool used in this study has been provided (see Appendix B).
Permission of partial use of the oral contraceptive knowledge tool questions was granted (see
Appendix C). To confirm accuracy in the selection of partial use of the questions, three expert
medical providers (i.e., a family practice or OBGYN, an emergency medicine physician, and a
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women’s health nurse practitioner) were selected to review the questionnaire. They determined,
via email, the rationality of question content that pertained to this research topic (see Appendix
D).
Data Collection, Management, and Analysis Plan
Following approval from the Abilene Christian University’s Institutional Review Board
(IRB), participants were recruited for involvement in this research study. Recruitment was
performed using flyer advertisements via the clinic and social media. Originally, participants
were to be recruited in person. It was intended to recruit in local doctor’s offices in Memphis,
Tennessee, and the physician in charge granted approval. Recruitment was to be done via the use
of social media and placing flyers around local campuses and universities, as well as clinics. A
local community center would have been the location for a one-day, two-hour session to collect
consents, data, and provide light snacks and beverages. Envelopes with random numbers
corresponding with participants’ seats were to be used to keep information confidential and
nonbiased. Random drawings would be done using the seat numbers.
Since the event of the COVID-19 pandemic and mandated social distancing, an
alternative method of data collection was created. In the absence of being able to meet in person,
enrollment to recruitment was completed via social media with flyers that included my contact
information. Recruiting was successfully done using social media (i.e., Facebook and Instagram)
and word of mouth with the IRB-approved flyer. In the wake of the global COVID-19 pandemic,
performing research has forced researchers to become innovative in recruiting, disseminating,
and collecting data. As a result, everything was done virtually utilizing email, Hello Sign for
consents, SurveyMonkey, and Zoom to communicate and collect data. Confirmation of intent
was emailed to the participant(s) and requests for consent utilized Hello Sign. Once consents
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were received, participants received detailed emails advising them of the process to complete the
presurvey demographic form. After demographic and presurveys were collected, participants
were emailed an option of three dates and times to select and join a brief 10- to 15-minute
PowerPoint question and answer educational session about birth control and stroke via Zoom
(see Appendix F). Once participants completed the informative Zoom session, they emailed a
postsurvey to complete the research process.
All participant information was placed on an Excel sheet by their email address in which
their progress was tracked for completion of the consent, demographic, pre- and post-survey, and
educational session. Participants were selected based on their ages (20–40) and being African
American females using or having used oral contraceptives (both estrogen and progesterone),
without use for hormonal replacement therapy, and no previous history of stroke. Interested
participants meeting these criteria were then emailed the SurveyMonkey link for the
prequestionnaire. Random numbers starting with 1–70 were assigned to participants as consents
were received; this was used to track participants, and names were replaced to maintain
confidentiality. Settings were also set in SurveyMonkey to omit participants’ names and contact
information as results of the questionnaires were returned to me to prevent bias of survey results.
Participants were given 48 hours from the date of receipt to complete all surveys, and they
received daily reminders.
After completing the prequestionnaire, participants were sent a link to vote on the date
and time to attend the educational session via Zoom. Once the participants selected their Zoom
presentation date and time, a link was emailed to them to dial in for the audio and visual
presentation of my educational content. I set Zoom settings so no participants were visible. The
educational presentation took 15 minutes, and after the presentation, participants were given time
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to ask questions. In each link, and during the presentation, participants were reminded of their
ability to withdraw at any time without any penalty or affecting their healthcare. Once all
questions or concerns were addressed, participants were emailed the link for their final posttest
in which they were given 24 hours to complete, and they were sent a reminder email at the 12hour mark.
All questionnaires took no longer than 15 minutes to complete. Data collection consisted
of participants receiving a presurvey of 16 questions regarding the mechanism of action, use,
side effects, and risks associated with oral contraceptive use. There were no changes in the
postsurvey questions that participants received immediately after completing their educational
sessions. Pre- and posttest questions were scored utilizing a Likert scale with one point for each
question. The highest possible score participants could receive was a 16 for the pre- and postsurveys. Based on the results, there were improvements noted in the participants’ knowledge as it
relates to oral contraceptives and stroke.
I did six random drawings throughout the study utilizing participants’ randomly assigned
numbers for $10 Amazon e-cards, which were emailed to the winners. All data were input into
an Excel sheet and saved on a secured drive. Only numerical data and results without the
participant’s identity were shared for analysis with the statistician. All data collected are stored
in a secure university Google drive.
The research’s structure was based on a quantitative research design and a t-test research
statistical analysis. This was performed to understand how the independent variables impact the
dependent variables. The goal was to determine if implementing an educational session would
enhance the participants’ knowledge of oral contraceptive use, risks, and benefits. The use of this
t test provided analysis to determine the effectiveness of the educational course and any
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knowledge gaps (Kellar & Kelvin, 2013). In this case, the study examined the knowledge of preand posteducation on oral contraceptive use, risks, and side effects.
The sample size of 70 was selected and calculated by the statistician based on the
expected odds ratio of ischemic stroke. Currently, no previous research reported standard
deviations. I sought a sample size of N = 70 to allow for a standard deviation of approximately
4.0 or less.
Methodology Appropriateness
A quantitative research design was implemented for this project. There was no control
group. Comparison was done with the participants’ pre- and postdata. Data analysis was
performed utilizing the t test to compare oral contraceptive (OC) knowledge pre- and
posteducational sessions using SPSS version 26. Permission was granted via email (see
Appendix E) to use the OC knowledge questionnaire that was modified to use 16 questions and
was given in one setting over a two-hour period before and after the educational session. The
participants signed the consent form agreeing to participate, and these were collected.
Participants were informed they could withdraw consent and or participation at any time without
penalty.
Feasibility and Appropriateness
I currently practice in an educational and occupational health setting. Although I do not
specialize in hematology, clots and strokes associated with oral contraceptive use is a concern for
this patient population. Participants were recruited using social media (i.e., Facebook and
Instagram) by posting a flyer and by word of mouth. The intervention provided education to
participants regarding the use, risks, and benefits of oral contraceptives as it pertains to stroke.
The IRB granted the flyer’s approval and the use of social media as a means of recruiting
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participants (see Appendix E). Six random drawings occurred throughout the research process
for a $10 Amazon gift card. I assumed all administration material such as paper envelopes, ink
cartridges, Wi-Fi, and gift cards, which was absorbed through a scholarship through the
Tennessee Nurses Association.
Institutional Review Board Approval and Process
Abilene Christian University requires students to obtain IRB approval before
implementation of DNP projects. Ethics CORE was completed in September 2019. The IRB
requires this training to be completed by investigators and all committee members,
administrators, and those involved with advising me on this project. The ethics CORE training
courses covered information, including subjects’ rights, consent, withdrawals, risks, benefits,
confidentiality, and research funding (ACU Office of Research & Sponsored Programs, 2019).
The IRB approval was begun in April 2020 and granted on May 15, 2020 (see Appendix E).
Revisions were granted to increase the age and inclusion criteria of African American women
ages 20–40 that have ever taken oral contraceptives. Approval was granted for an exempt
research project.
Interprofessional Collaboration
I am a DNP student practicing in an occupational clinic setting. Healthcare providers are
vital stakeholders in this POI. Other stakeholders are participants of the study. Once the project
was ready to implement, I assisted in recruiting participants by advertising via social media,
email, and word of mouth. Obtaining the right sample size was imperative, and those interested
were referred to me. I determined if participants met the inclusion criteria. The subjects relied on
me to provide accurate information as it pertains to oral contraceptive use. The IRB approved the
request to proceed with the study while protecting human subjects (see Appendix E).
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Before participation in the study, consent was obtained by the participants and
verification of inclusion criteria was performed. Interprofessional collaboration with participants
was completed with the inclusion of medical health professionals (i.e., obstetrician, emergency
room, and women’s health) and a statistician for data accuracy and validity. Weekly reviews of
the data provided a useful communication tool to address and rectify any issues before
proceeding.
Practice Setting
This research’s location was completed virtually in my home and the homes of
participants for purposes of the COVID-19 pandemic and meeting social distancing health
department guidelines. Qualified participants were provided with the 16-question knowledgebased questionnaire. This information was then examined to determine the patient’s knowledge
base of oral contraceptive use, risks, and side effects. Participants were recruited via social media
through the use of Facebook, Instagram, and word of mouth. Participants were given the option
to contact me if they had questions once reading the criteria on the flyer that was circulated on
social media. This setting was selected as the safest recruiting means due to the pandemic and to
obtain the most interest. I continued to use electronic means of communicating with participants
through email for consents, demographic forms, and surveys.
Target Population
The target population for this POI was African American women ages 20–40 using or
having used oral contraceptives. The women had no history of clots or strokes. The reasoning for
oral contraceptive use was not limited to family planning. Participants qualified if they were
using oral contraceptives for alternative reasoning such as acne and menstrual regulation. Any
inclusion and exclusion criteria were necessary to maintain the efficacy and accuracy of the
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research process. The demographic of the participants focused on African American women in
childbearing ages 20–40. These participants were currently utilizing oral contraceptives or have
used them in the past with no specific reasoning in mind. Inclusion criteria consisted of African
American women ages 20–40 that have ever used oral contraceptives. Exclusion criteria for this
quality improvement project included the following:
•

Non oral contraceptive use,

•

history of a previous stroke,

•

ethnicity other than African American,

•

<20 years of age,

•

>40 years of age, and

•

currently on hormonal replacement therapy.

Risks and Benefits
The risks of this study were participant involvement, privacy, and environmental. Since
participants are currently on oral contraceptives or have taken them in the past, some knowledge
can be assumed; however, accuracy and understanding are crucial to closing the gap. The risk
was minimized with measures such as ensuring that information was kept securely, and
conversations held in a secure environment. The data were collected and analyzed as efficiently
as possible with the aid of research Excel sheets to keep organized.
Collecting and analyzing this data provided evidence of the importance of educating
patients and understanding that participants are at more risk by a lack of knowledge of oral
contraceptive use, risks, and side effects. Essentially, the goal of this POI was to bring
awareness, to educate, and to decrease the incidence of stroke-related symptoms from using oral
contraceptives.
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Conflict of Interest
I am an ambassador volunteer with the local Mid-South American Heart and Stroke
Association. I did not review any participants’ Health Insurance Portability and Accountability
Act (HIPAA) related information.
Timeline
The timeline of this study is outlined in an appendix (see Appendix G). The scholarly
project was initiated at the DNP program start (May 2018) and carried on through program
completion (anticipated no later than October to December 2020).
Chapter Summary
This quantitative design aided in determining the effectiveness of educating patients on
oral contraceptive use, risks, and side effects as it pertains to stroke. This method was most
appropriate as it focuses on preventative measures. Awareness and education are vital
components to ensuring safe prescribing practices are being implemented into practice. This tool
enabled patients with the ability to understand better the use, risks, and side effects of oral
contraceptive use as it pertains to stroke. Statistical analysis was performed utilizing a t test to
determine if the implementation of an educational session would increase the participants’
knowledge base of oral contraceptive use, risks, and side effects as it pertains to stroke (Kellar &
Kelvin, 2013). Obtaining approval to perform this study was done through ACU with IRB ethical
procedures in place.
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Chapter 4: Results
The research was successfully implemented; however, the time frame varied with some
changes for recruiting purposes. I successfully disseminated educational information to
participants and obtained consent, demographic data, and pre- and postquestionnaires
electronically, as previously stated. Obstacles occurred out of my control, and changes were
made accordingly with appropriate IRB approval. One change was extending the age range from
30–40 to 20–40. During recruitment, it was identified that many women were no longer on oral
contraceptives; however, they had previously used and were currently using other forms of
contraceptives such as an intrauterine device and a Depo-Provera injection. The inclusion of this
patient population was also approved by the IRB to capture the required participants. A strength
of this quality improvement project was the ability to determine knowledge deficits in this highrisk population. The study also gives healthcare providers insight into the importance of relying
on the information before medication administration. The study’s weakness would be the amount
of time it took to gather data from participants with sending multiple emails. Another weakness
would be biases in the results as I am a stroke survivor. It is recommended for future research to
utilize technology as a means for recruitment and capturing participants. Although it was not
initially the planned option of recruiting participants, technology was convenient for both the
participants and me. Evolving healthcare and technology requires an innovative edge to stay
current with research. Utilizing technology for recruiting and data collection will also expedite
the dissemination of evidence-based practices at the bedside.
One limitation of this quality improvement project’s scope was the onset of the COVID19 pandemic and the inability to recruit in the community as social distancing and lockdown
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orders were set in place. The pandemic also created additional stressors for the participants, such
as loss of work and illness, which decreased interest in participating in the study.
Purpose of the Project
This research aimed to bring awareness of risk factors about clots and strokes related to
oral contraceptive use. It was also intended to enhance participants’ knowledge while providing
them with education and awareness of risk factors, signs, and symptoms of a stroke. This
educational intervention was created to prevent the subsequent incidence of blood clots or stroke
from oral contraceptive use.
Discussion of Demographics
Demographics were initially based on African American participants, ages 30–40, using
oral contraceptives. However, the criteria had to be later changed to include a broader age range.
Once recruitment began, it was found that many participants were not in this 30–40 age range or
currently taking oral contraceptives. Today’s world of medicine offers women many
contraceptive options, and many women have opted to utilize implants and injections as a form
of contraceptive. To meet the required sample size and deadlines and with IRB approval, the age
range was increased to African American women ages 20–40 and those who have used oral
contraceptives. Participants were given an eight-question demographic form to complete. The
demographic form questions consisted of age (see Table 1), education, number of pregnancies,
type of oral contraceptive use, length of time, the rationale for using an oral contraceptive,
smoking, and stroke history. With the increased sample criteria, the average age of participants
was 32. Out of the 69 participants, most hold graduate degrees, followed by a bachelor’s degree
with the least amount having associate degrees (see Table 2). Of the participants, 33.3% had
never been pregnant, and 23.2% have been pregnant at least once or twice (see Table 3).
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Precisely 44.9% of the participants are currently using estrogen- or progesterone-based oral
contraceptives and only 6% on progesterone-only (see Table 4). Most participants stated they
used oral contraceptives for six or more years (see Table 5). The primary use for oral
contraceptives was for family planning purposes with regulating the menstrual cycle as the
second most selected reason (see Table 6). There were two smokers with no history of stroke
reported by participants (see Table 7).
Demographic Results
Table 1
Age of Participants

Age

N

Minimum

Maximum

69

20.0

40.0

M
31.877

SD
6.0015

Table 2
Education of Participants
Education
High school
Associates degree
Bachelor’s degree
Graduate degree
Total

f
17
4
20
28
69

%
24.6
5.8
29.0
40.6
100.0

Cumulative %
24.6
30.4
59.4

f
23
16
16
1
13
69

%
33.3
23.2
23.2
1.4
18.8
100.0

Cumulative %
33.3
56.5
79.7
81.2

100.0

Table 3
Number of Pregnancies
Number of Pregnancies
0
1
2
3
More than 3
Total

100.0
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Table 4
Use of Contraceptives
Contraceptive Type
Estrogen only
Progesterone only
Estrogen or progesterone
Don’t know
Total

f
11
6
31
21
69

%
15.9
8.7
44.9
30.4
100.0

Cumulative %
15.9
24.6
69.5

f
20
10
10
22
7
69

%
29.0
14.5
14.5
31.9
10.1
100.0

Cumulative %
29.0
43.5
58.0
89.9

f
2
42
20
5
69

%
2.9
60.9
29.0
7.2
100.0

Cumulative %
2.9
63.8
92.8
100.0
100.0

Number of Years
f
3
1
10
1
Never smoked
67
Total
69
Note. No participants reported a history of stroke.

%
1.4
1.4
97.1
100.0

Cumulative %
1.4
2.9

100.0

Table 5
Length of Time Using Contraceptives
Years
1–2
3–4
5–6
More than 6
Don’t know
Total

100.0

Table 6
Reasons for Using Contraceptives
Reasons
Acne
Family planning
Regulating cycle
Other
Total
Table 7
Smoking History of Participants

100.0
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Data Analysis
The analytic method used for this outcome research project did not deviate from its
original plan. Participants received presurveys, educational sessions, and a posttest. A descriptive
statistic (see Tables 8 and 9) was performed for the pre- and postsurveys regarding the use, side
effects, risks, and benefits of oral contraceptives and the risk factor signs and symptoms of a
stroke (Kellar & Kelvin, 2013).
Table 8
Pretest and Posttest Descriptive Statistics of Oral Contraceptive Knowledge Questionnaire
Pretest score
Posttest score

N
69
69

Minimum
0
0

Maximum
16
13

M
9.03
10.80

SD
3.185
2.019

Table 9
Overall Paired Sample t Test for Pre- and Post- Oral Contraceptive Knowledge Questionnaire
Results
Mean

SD

Difference
Posttest score

1.768

2.573

95% Confidence Interval
of the Difference
Lower

Upper

1.150

2.386

t

Sig.
(two-tailed)

5.707

.000

Pretest score
The results proved there was a significant improvement in knowledge after oral
contraceptive and stroke education. The noted areas with the most increase included blood clots,
stroke, and heart attack while taking oral contraceptives (Kellar & Kelvin, 2013).
This method was most appropriate in examining the data before and after education to
determine the potential knowledge deficits. The original, which required 70 participants, was not
met due to recruiting changes because of the limited ability to go into public facilities due to the
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COVID-19 pandemic and to meet deadlines. Initially, 73 participants were successfully
recruited; however, they could not complete the entire research process. One participant was
disqualified as she had a stroke history, which was one of the exclusion criteria. Another
participant expressed interest and signed consent, but did not complete the process. Three other
participants also expressed interest via email, signed the consent, completed the demographic
and presurvey, but failed to respond to email correspondence to complete the Zoom educational
session or postsurvey. As a result, there were a total of four withdrawals.
Approval was granted by Dr. Hall, the original author of the oral contraceptive
knowledge questionnaire tool, using 19 questions versus the original 40. A professional
healthcare panel also reviewed the questions for this research topic’s appropriateness. Three of
the questions were fill in the blank definition questions regarding blood clots, heart attack, and
stroke and were not included in the scoring. Performing a data analysis is a vital component to
ensuring the accuracy of data collected.
This quantitative research utilized descriptive statistics to determine the effectiveness of
the educational sessions provided to the participants (Kellar & Kelvin, 2013). A power analysis
was performed of the research data, and a difference between means was 1.77, the standard
deviation was 2.6665, the sample size group was 69, the alpha level was 0.05, and the power
(two-tailed test) was 0.972. Ultimately, the power for the data was 97.2%, and the accepted
power is 80% or higher.
A chi-square test of independence was performed to examine whether a correct answer
for Question 1 was independent of when a respondent completed the survey (before or after the
intervention). The results of the chi-square test revealed a significant relationship between a
correct answer for Question 1 and when a respondent completed the survey, χ2 (1, N = 69) =
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11.739, p = .001. Tables 10 and 11 display the results of the cross-tabulation and the chi-square
test for Question 1. The results of the chi-square revealed a significant relationship between
whether a participant provided the correct answer and whether the participant had received the
intervention.
Table 10
Contingency Table for Responses to Question 1: Cross-Tabulation
Incorrect
Correct
Total
Pretest
19
50
69
Posttest
4
65
69
Total
23
115
138
Note. Question 1 was true or false response if the pill has either a combination of estrogen or
progestin only.
Table 11
Contingency Table for Responses to Question 1: Chi-Square Tests
Value
Pearson chi-square
Fisher’s exact test

11.739

Asymptotic
Significance
(two-sided)
.001

Exact Sig.
(two-sided)

Exact Sig.
(one-sided)

.001

.001

Question Guiding the Inquiry
The PICOT question was, Will an evidence-based educational session assist with
increasing awareness of stroke with oral contraceptive use in African American women ages 20–
40? Results showed a mean of 9.03 and a standard deviation of 3.185 for the pretest score and
the posttest had a 10.80 mean with a 2.019 in standard deviation. The posttest is the difference
between the pre- and posttest, which was 1.768 with a 2.573 overall standard deviation. The test
was set at a 95% confidence interval of 2.386 (see Table 9).
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Reliability and Validity
This study used previous research questions as the intervention. Contingency tables were
used to show relationships between the pre- and post-survey responses. A chi-square and
Fisher’s exact test analyzed the data and ensured the smaller sample size’s accuracy. The
Fisher’s exact was most appropriate to ascertain that the posttest results were not by chance. The
questions used were also reviewed by a panel of three healthcare professionals to determine the
appropriateness for purposes of this research. With the smaller sample size, the confidence
interval states the results are 95% true (Kellar & Kelvin, 2013).
Interpretation of Findings and Inferences
Overall, the N = 69 sample size was sufficient to determine the effectiveness of the
intervention. Participants scored highest in the risk-related questions for taking oral
contraceptives, specifically relating to questions of blood clots, stroke, and heart attack that saw
the most improvements. The results also aligned with previous research, which showed gaps in
cardiovascular disease preventative efforts in young women (Chaturvedi et al., 2016). African
American women ages 20–40 lack the knowledge of oral contraceptive risks as it pertains to
stroke and heart disease. It also showed that despite 40.6% of participants holding a graduate
degree (see Table 2), there were still knowledge gaps. The pretest and posttest can infer the
training regarding oral contraceptives and stroke prevention did show a significantly positive
effect in the participant’s overall knowledge of the possible health consequences for using oral
contraceptives related to stroke. It can be inferred that participants received knowledge to make
more informed decisions regarding the safest birth control based on their risk factors. It can also
be inferred African American women ages 20–40 lacked education on stroke and heart disease
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and need reinforced education regarding risk factors, signs, and symptoms as a means of
prevention.
Chapter Summary
A quantitative research study was performed to determine the effectiveness of an
intervention. The intervention was replicated from previous research studies to answer the
PICOT question: Will implementing evidence-based education increase awareness of stroke in
oral contraceptive use of African American women ages 20–40? A smaller sample size of 69 was
confirmed through power analysis and reliable enough to gather necessary data. A Fisher’s exact
test proved a significant increase in participant knowledge after receiving oral contraceptives and
stroke education. A confidence interval of 95% revealed the accuracy of research results (Kellar
& Kelvin, 2013). Although most participants held graduate degrees, it was revealed that a
knowledge deficit existed as it pertained to oral contraceptive use and stroke.
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Chapter 5: Discussion, Conclusions, and Recommendations
The oral contraceptive and stroke education was effectively implemented. There were
some changes made with increasing the inclusion criteria to allow those in their 20s and those
who have ever utilized oral contraceptive to participate. The goal to increase awareness in this
patient population was necessary, as 90% of women have at least one risk factor of heart disease
or stroke (ASA, 2020). Previous research assessing participants’ knowledge of oral contraception
noted an increase in the mechanism of action and effectiveness, whereas this study showed the
most improvement with risks such as blood clots, stroke, and heart attack (Hall et al., 2013).
Although there were changes in the sample size, it was appropriate based on the power
analysis two-tailed test that proved a difference between means of 1.77, a SD = 2.665, and 0.05
alpha, which confirmed 95% accuracy in the data analyzed. The oral contraceptive and stroke
education analysis was based on a paired sample t test, which showed a significant difference of
5.707 between the pretest and posttest participants took. This signifies strong evidence and
effectiveness of oral contraceptive and stroke education. The data also proved that despite
participants’ educational attainment, there were gaps in knowledge requiring intervention (Kellar
& Kelvin, 2013).
The most significant increases in knowledge noted was in the use of oral contraceptive
question number 14, which asked participants if they have trouble breathing would they call their
doctor immediately, discuss it at their next visit, or not tell? There was a 124-point increase
posteducation with participants knowing the importance of contacting their doctor immediately if
exhibiting difficulty breathing (see Tables 12 and 13).
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Table 12
Contingency Table for Responses to Question 14: Cross-Tabulation
Incorrect
Correct
Total
Pretest
5
64
69
Posttest
2
67
69
Total
7
131
138
Note. Question 14 asked participants if they had trouble breathing would they call the doctor
immediately, discuss at their next visit, or not tell?
Table 13
Contingency Table for Responses to Question 14: Chi-Square Tests
Value
Pearson chi-square
Fisher’s exact test

1.354

Asymptotic
Significance
(two-sided)
.245

Exact Sig.
(two-sided)

Exact Sig.
(one-sided)

.441

.220

Based on the results, participants scored very high in the risk for the blood clots question.
The participants showed an increase of 104 points between the pretest and posttest when
questioned about the risk for blood clots while taking oral contraceptives (see Tables 14 and 15).
There was a score improvement noted in the question regarding oral contraceptives and increases
in stroke risk. The risk for stroke knowledge increased by 98 points, proving a better
understanding of participant risks of acquiring blood clots and stroke while on oral
contraceptives (see Tables 16 and 17).
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Table 14
Contingency Table for Responses to Question 8: Cross-Tabulation
Incorrect
Correct
Total
Pretest
14
55
69
Posttest
3
66
69
Total
17
121
138
Note. The question asked participants if the pill increases, decreases, or has no effect on the risk
of blood clots?
Table 15
Contingency Table for Responses to Question 8: Chi-Square Tests
Value
Pearson chi-square
Fisher’s exact test

8.118

Asymptotic
Significance
(two-sided)
.004

Exact Sig.
(two-sided)

Exact Sig.
(one-sided)

.008

.004

Table 16
Contingency Table for Responses to Question 9: Cross-Tabulation
Incorrect
Correct
Total
Pretest
17
52
69
Posttest
3
66
69
Total
20
118
138
Note. Question 9 asked participants if the pill increased, decreased, or had no effect on the risk of
stroke.
Table 17
Contingency Table for Responses to Question 9: Chi-Square Tests
Value
Pearson chi-square
Fisher’s exact test

11.461

Asymptotic
Significance
(two-sided)
.001

Exact Sig.
(two-sided)

Exact Sig.
(one-sided)

.001

.001
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Participants also showed an increase in understanding hormones in the pill and how it
affects their bodies. Results revealed a 92 point increase of knowledge in the pill’s hormonal
content (see Tables 10 and 11). The 92 point increase of knowledge noted in understanding
hormones in the pill are like those made in a woman’s body (see Tables 10 and 11). The oral
contraceptive and stroke education provided participants with an enhanced knowledge of what
they are taking or have taken in the past.
Participants were also noted to have an increase in knowledge regarding the use of oral
contraceptives. There was an 86 point increase in scores regarding leg pain and swelling. The
women showed a better understanding of notifying their provider when they are exhibiting leg
pain or swelling (see Tables 18 and 19).
Table 18
Contingency Table for Responses to Question 12: Cross-Tabulation
Incorrect
Correct
Total
Pretest
19
50
69
Posttest
7
62
69
Total
26
112
138
Note. Question 12 asked participants if they had leg pain or swelling, what would they do?

Table 19
Contingency Table for Responses to Question 12: Chi-Square Tests
Value
Pearson chi-square
Fisher’s exact test

6.824

Asymptotic
Significance
(two-sided)
.009

Exact Sig.
(two-sided)

Exact Sig.
(one-sided)

.015

.008
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Implications of Analysis for Leaders
Regardless of the patient’s educational attainment, the research proves previous or
current use of oral contraceptives that participants lack the knowledge of the mechanisms of
action, use, risks, and benefits. Healthcare providers have due diligence in ensuring that patients
are informed adequately before prescribing medications. Also, providers must be looking at the
patient. Holistically viewing the patient would include taking time to review risk factors and
working with the patient to make informed decisions on safely using oral contraceptives.
As a secondary prevention measure, providers and patients would benefit from ensuring
that adequate information is disseminated to women upon prescribing oral contraceptives.
Providing appropriate education for patients could decrease risk factors and improve stroke
incidence in this population. With 80% of strokes being preventable, the oral contraceptive
stroke education session could reduce the incidence of stroke (ASA, 2020). Educating this highrisk population will aid in promoting health and wellness. This will also empower African
American women to not only get involved in their care but also advocate for themselves when
they are experiencing any symptoms. These are all vital elements of implementing Martha
Rogers’ unitary theoretical framework at the bedside. Incorporating this theoretical framework
will address the knowledge gaps noted in the research while providing holistic and competent
patient-centered care (Nursing Theory, 2016).
Essentials of Doctoral Education for Advanced Practice Nurses
Essential I: Scientific Underpinnings
Stroke among African American women is a significant concern. It is concerning because
most African American women are not aware of their risk factors. In doing this research, it was
noted that this patient population lacked the knowledge requiring them to make informed health

43
decisions. The results also indicated a lack of holistic patient-centered care. As a DNP graduate,
it is key to ensure the development and implementation of policy into practice, incorporating
Rogers’ unitary health model. Providers viewing the patient holistically and inclusive of their
healthcare are necessary to mitigating healthcare disparities (Nursing Theory, 2016). Patient care
is not to be limited to assessing, diagnosing, planning, implementing, evaluating, and
educating—holistic patient care is inclusive in educating and collaborating efforts between the
provider and patient.
Essential II: Organizational and Systems Leadership for Quality Improvement and Systems
Thinking
Improving quality patient care can be done through the utilization of evidence-based
research. Performing ongoing research will be crucial to improving quality care and specifically
those in high-risk and underserved populations. This quality improvement project was created
based on my personal experiences and the need to educate and advocate for African American
women. Understanding the risk African American women ages 20–40 have as it pertains to
stroke and the risks of oral contraceptive use was limited in the research and would require
ongoing investigation. Developing a risk factor algorithm for this patient population based on
past evidence-based research could be pivotal for providers and patients.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice
The research results acquired in this project can aid in improving prescribing practices.
Providers can utilize this evidence-based data to enhance their prescribing techniques to include
more education of medications, including use, risks, and benefits. Doctor of Nursing Practice
graduates performing evidence-based outcome projects can enhance the practices at the bedside.
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The analyzed data can also guide the necessary policy change to practice while improving health
disparities among high-risk populations.
Essential IV: Information Systems, Technology, and Patient Care Technology for the
Improvement and Transformation of Health Care
Since the wake of the COVID-19 pandemic, healthcare has seen a shift in patient care
delivery. Technology has taken the forefront in implementing patient care. The most common
format would be utilizing telecommunication, such as Zoom conferencing, to educate and
disseminate information. Teleconferencing was most effective for disseminating information and
reaching participants in a timely fashion. This was the most beneficial and effective for this
quality improvement project. It was also a convenient means of capturing this high-risk patient
population. Evolving healthcare requires DNP graduates to stay up to date with technological
advances to provide safe, quality patient care.
Essential V: Healthcare Policy for Advocacy in Healthcare
Results from this quality improvement outcome project indicated the need for educating
patients on the mechanisms of action, use, and risks of oral contraceptives. It also showed the
need to implement additional measures, such as risk factor algorithms, to identify those at high
risk. As a nursing leader, a DNP graduate will have the ability to create and implement this
necessary tool at the bedside to reduce risk factors and the incidence of stroke in this patient
population.
Essential VI: Interprofessional Collaboration for Improving Patient and Population Health
Outcomes
Doctor of Nursing Practice graduates work collaboratively with other healthcare
professionals to improve the patient’s quality of care. This quality improvement project required
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a collaborative effort between me, nursing faculty, statistician, and participants. The leadership
skills acquired as DNP graduates will enable one to work in this evolving world of healthcare.
Nursing leaders can provide patient-centered care and improve outcomes by disseminating more
quantitative research projects such as this.
Essential VII: Clinical Prevention and Population Health for Improving the Nation’s Health
Stroke carries a heavy burden on patients and families. It has become more prevalent
among young adults and accounted for $17.9 million in one year (Tong et al., 2019). Knowledge
and preventative care will be vital in addressing the two to three times higher incidence of stroke
in African American women (ASA, 2020); knowledge preventative care is vital. To address the
disparities, it will require DNP graduates to utilize their knowledge of epidemiology and
statistics to understand disease processes better as it pertains to the community and population’s
health. Doctor of Nursing Practice graduates are trained to be diverse in their learning and
clinical practice. Providing disease prevention through education and screenings can bridge the
knowledge gaps and healthcare disparities in African American women.
Essential VIII: Advanced Nursing Practice
Competent nursing leaders in specialty areas such as community health settings are
necessary to provide reasonable, safe patient care. Collecting and analyzing data can guide
practitioners in designing protocols based on evidence-based practice. Implementation of quality
outcome projects into practice will guide and advanced practitioners to make appropriate clinical
judgments. Implementing necessary policy changes such as risk factor algorithms can address
knowledge gaps and improve patient outcomes.
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Recommendations for Future Research
Women use oral contraceptives for a variety of reasons. Reasons can range from family
planning, hormone regulation, to menstrual pain. On average, more than 50% of women using
oral contraceptives are African American (Daniels & Abma, 2018). With such a large portion of
this high-risk population utilizing oral contraceptives, they still face a knowledge deficit. African
American women ages 30 and up are the number one cause of death related to heart disease and
stroke (ASA, 2020). The mean age of participants completing this research was 31; this is
alarming as 80% of strokes are preventable (ASA, 2020). Our patient’s health is at stake and
needs intervention to rectify and mitigate further health disparities. Future research would be
necessary to understand why African American women ages 20–40 are being prescribed oral
contraceptives without proper education. More research should be done to understand better how
providers are prescribing oral contraceptives. Additionally, performing research to include
providers and understand why these women are not adequately educated before prescribing oral
contraceptives would be warranted based on this study’s results. Implementing a brief
educational session upon prescribing and reinforcing usage at subsequent visits may be
beneficial.
Additional research needs to be completed on stroke as it relates to contraceptives. The
knowledge deficit identified in this research proves there is a need for future investigation on the
topic. Roughly 90% of women have at least one risk factor for heart disease or stroke (ASA,
2020). A recommendation for implementing an evidence-based algorithm of risk factors to
determine if a woman would be the right candidate for oral contraceptives would be beneficial in
not only educating but also decreasing incidences. Current prescribing recommendations are
based on blood pressure, diabetes, age, and smoking. Reviewing the patient holistically and
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understanding her reasoning for oral contraceptive use would benefit both the patient and
provider. Doctor of Nursing Practice graduates can provide evidence-based outcomes research to
implement at the bedside to enhance knowledge and improve health disparities while reducing
incidence.
Implementing this research into evidence-based practice would allow providers to capture
those knowledge deficits about oral contraceptive use. Patients could become more involved
with their care and have mutual partnering with their providers to make informed decisions. It
will also increase awareness of increased risk factors in this patient population for providers to
focus on alternative contraceptives. Clinical practice may need to include lab testing of hormone
levels (i.e., estrogen and progesterone) as it has been found that combination hormone therapy
poses the highest risk of blood clots, stroke, and heart attack (Schuiling & Likis, 2013).
Incorporating lab testing of estrogen and progesterone levels before prescribing may
mitigate the increased risk of vascular incidents in this high-risk population. Another lab test to
consider is the inclusion of D-dimer as a predictor test for women using oral contraceptives. Ddimer is a lab test for clot formation. Research has shown it to be a coagulation biomarker and
higher in African Americans (Raffield et al., 2017). Research data would need to include
contraceptives of all types to determine any knowledge deficits or stroke incidence (Camara et
al., 2017). Including other contraceptive use and stroke would give a more concise picture of
overall contraceptive knowledge and its effects. Other research data noted gaps in preventative
efforts for cardiovascular disease in young women. It was also suggested to implement the
cardiovascular index risk factor indicator as a vascular disease prevention assessment tool when
prescribing oral contraceptives to this patient population (Chaturvedi et al., 2016).
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Chapter Summary
Despite the smaller sample size N = 69, the oral contraceptive knowledge tool pretest
showed participants were deficit in the necessary information on understanding oral
contraceptive use, side effects, and risks. Utilizing the Fisher’s exact test for reliability was most
effective in obtaining accurate pretest and posttest results (Kellar & Kelvin, 2013). The oral
contraceptive stroke education session was proven to be a positive intervention. There was a
knowledge increase noted with the most improvements in two areas: risk and use of oral
contraceptives.
Participants are now more aware that oral contraceptives can cause blood clots, stroke,
and heart attacks and are aware of their signs and symptoms (see Tables 10, 12, 14, 16, 18, 20,
and 21). Participants also have a better understanding of what oral contraceptives contain and
how it affects their bodies. The intervention can enable African American women ages 20–40 to
make more informed decisions about oral contraceptives. Providers will need to be vigilant with
incorporating more education before prescribing oral contraceptives. Reiteration of risk factors
as it pertains to oral contraceptives and stroke may also be necessary. Additionally, incorporating
hormone-level testing before prescribing oral contraceptives is another vital component. These
secondary prevention tools can guide providers in reducing the incidence of stroke in this highrisk population. To improve patient outcomes, providers will need to continue to educate
themselves and patients. Healthcare professionals can be collaborative with patients by
empowering them with an adequate education. The use of technology in research can help reach
patients at all levels and specifically those in the high-risk populations. Ongoing research will be
necessary for policy change and implementation for the enhancement of care at the bedside.
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Table 20
Contingency Table for Responses to Question 10: Cross-Tabulation
Incorrect
Correct
Total
Pretest
25
44
69
Posttest
7
62
69
Total
32
106
138
Note. Question 10 asked participants if the pill increases, decreases, or has no effect on the risk
of heart attack.
Table 21
Contingency Table for Responses to Question 10: Chi-Square Tests
Value
Pearson chi-square
Fisher’s exact test

13.182

Asymptotic
Significance
(two-sided)
.000

Exact Sig.
(two-sided)

Exact Sig.
(one-sided)

.000

.000
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Appendix A: Permission to Use Questionnaire

Article I.

Permission to use the tool

Dec 19,
2018, 3:35
PM

To Kelli
Dr. Hall,
Thanks for your speedy response. I am referring to your 2013 research in which you utilized the
41-item knowledge questionnaire. My focus would be more on MOA and side effects. I would
also like to implement the educational text messaging or email as a tool to determine pre and
post education for participants.

Article II. Hall, Kelli < >
To me
Thanks for clarifying! Sure you have my permission. Good luck with your project!
Kelli
Sent from my iPhone

Dec 19,
2018, 4:50
PM
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Appendix B: Stroke Prevention and OC Knowledge Questionnaire
1. The pill has either a combination of estrogen and progestin or progestin only.
True
False
Don’t know
Not related
2. The pill contains hormones that are very different from those made by a woman’s body.
True
False
Don’t know
Not related
3. Please select whether you think the pill makes each symptom better, worse, or has no effect.
ACNE
Better
Worse
No effect
Don’t know
Not related
4. Please select whether you think the pill makes each symptom better, worse, or has no effect.
Menstrual cramps
Better
Worse
No effect
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Don’t know
Not related
5. Please select whether you think the pill makes each symptom better, worse, or has no effect.
Irregular periods
Better
Worse
No effect
Don’t know
Not related
6. Please select whether you think the pill makes each symptom better, worse, or has no effect.
Heavy periods
Better
Worse
No effect
Don’t know
Not related
7. Please select whether you think the pill makes each symptom better, worse, or has no effect.
Weight gain
Better
Worse
No effect
Don’t know
Not related
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8. Please describe what you think each of the following conditions is in your own words. Then
select whether you think the pill makes each condition increase, decrease, or has no effect.
Blood clots are...
9. The pill increases, decreases, or has no effect on the risk of blood clots?
Increases
Decreases
No effect
Don’t know
Not related
10. Stroke is...
11. The pill increases, decreases, or has no effect on the risk of stroke?
Increases
Decreases
No effect
Don’t know
Not related
12. Heart attack is...
13. The pill increases, decreases, or has no effect on the risk of heart attack?
Increases
Decreases
No effect
Don’t know
Not related
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14. For each health problem, select what you would do about taking the pill (stop or continue)
and about telling your doctor (call immediately, discuss at next visit, or not tell).
Leg pain or swelling
Stop taking
Continue taking
Don’t know
Not related
15. If you have leg pain or swelling, what would you do?
Call my doctor immediately
Discuss at next visit
Not tell
Don’t know
Not related
16. If you have trouble breathing, would you...
Stop taking
Continue taking
Don’t know
Not related
17. If you have trouble breathing, would you...
Call my doctor immediately
Discuss at the next visit
Not tell
Don’t know
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Not related
18. If you had chest pain, would you...
Stop taking
Continue taking
Don’t know
Not related
19. If you had chest pain, would you...
Call your doctor immediately
Discuss at next visit
Not tell
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Appendix C: Permission to Use Questionnaire Tool

Article III. Permission to use partial tool

Fri, Mar 6,
1:01 PM

To Kelli
Dr. Hall,
I was wondering if I could get permission to utilize 13 of your questions (78 c, g, I; 79 a, b, c, d,
& e; 80 b, d, h, I; 81 b, c, e. My PICO is Stroke Prevention in AA women ages 30–40 using oral
contraceptives, and I am trying to narrow the questions down to my specific topic. I have a
statistician that will run the reliability of using fewer questions but wanted to get your
permission. Would you be okay with my utilizing the questions that pertain to stroke/heart
disease?
Respectfully,
Ashanti L.N. Coleman, MSN, APRN,FNP-c
Fri, Mar 6,
1:13 PM
To me
Yes
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Appendix D: Expert Review
On March 11, 2020, three experts reviewed questions from the original oral contraceptive
knowledge questionnaire, and based on clinical expertise, agreed the 13 questions selected were
the most appropriate for this research project. These have been approved by Dr. Katosha Muse, a
primary care and obstetrician in her own practice in Memphis, Tennessee, Dr. Karen Green an
emergency room physician in a local hospital in Ohio, and Crystal Shotwell, APRN FNP-c, a
women’s health physician in labor and delivery at a facility in Memphis, Tennessee. Contact
information is available upon request.
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Appendix E: IRB Approval
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Appendix F: Stroke Prevention Educational Session (PowerPoint Presentation)
Stroke Prevention educational session.pptx
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Appendix G: Study Timeline
Task Date

Task

May 2018
May 2018

Engage facility site to coordinate affiliation agreement
Develop theoretical framework

May 2018

Choose study measurement tool; validate permission to
use (in writing)

July 2018

Develop PICOT question

December 2018

July 2019

Select project chair and engage in first meeting
Deadline for obtaining official support letter from
facility. Upload to NURS 755

March 2019

Secure chair and committee members, finalize
formation of committee form and upload to NURS 755

April 2019

Complete Chapter 1 of scholarly project and provide to
committee for feedback

January 2019

Complete Chapters 2–3 of scholarly project

August 2019

Revise and finalize chapters one through three. Submit
to committee for final approval
Coordinate proposal defense date with committee and
submit formal defense form

October 2019

October–November 2019

Mid program review: ensure compliance with eportfolio regulations, clinical log review, prepare for
proposal defense

August–September 2019

Continue preparation for proposal defense

September–October 2019

Proposal defense

November–December 2019

Work on IRB proposal and edits required

January–February 2020

Working on IRB proposals and edits

April–May 2020

IRB approval
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May–July 2020

Implementing project to recruit participants

June–July 2020

Participants engage in study

July–August 2020

Submission of data to statistician for assistance with
Excel formatting, upload data to SPSS for analysis

August–September 2020
October–December 2020

Continued revisions of Chapters 1–3 and draft of 4–5
Editor review of final draft of Chapters 1–5 through.
DNP final defense

